If you’re running a pharmaceutical marketing campaign in Australia, AHPRA verification isn’t optional — it’s essential. This article explains why marketing to an unverified audience wastes budget, creates compliance risk, and why a verified HCP audience is the foundation of every effective campaign.
Read more
The adoption of digital health technologies is growing, but many doctors remain hesitant due to concerns about security, usability, and workflow disruption. To accelerate adoption, digital health tech companies must focus on practical solutions that address these challenges.
Read more
The digital transformation of healthcare is well underway, with doctors increasingly turning to technology to improve efficiency and patient care. However, while adoption is growing, familiarity and confidence in digital health solutions remain mixed, highlighting the need for better integration and support.
Read more
Artificial Intelligence (AI) is increasingly being integrated into healthcare, promising to enhance efficiency, reduce administrative burdens, and improve patient outcomes. Yet why do so many doctors remain sceptical about its adoption.
Read more
Open-ended responses from a recent AusDoc survey provide valuable qualitative insights into how prescribing practices for GPs and specialists can be improved. These responses highlight key themes and practical recommendations for enhancing access to information and support for healthcare professionals.
Read more
Understanding the unique needs of GPs and specialists is pivotal for fostering better prescribing practices. By tailoring resources and engagement strategies, stakeholders can support informed decisions, ultimately improving patient care outcomes.
Read more
An AusDoc survey has highlighted an opportunity for the pharmaceutical industry to help speed up the pathway to diagnosis and treatment of patients with rare diseases.
Read more
While eight in every hundred Australians has a rare disease, GPs lack confidence in identifying these patients, which may delay diagnosis and treatment.
Read more
Most respondents to an AusDoc survey prescribe weight-loss medications at least once a month, with legacy products enjoying strong brand recall alongside the newer entrants to the market.
Read more
More than 85% of doctors report an increased number of patients asking about weight-loss medication over the past 12 months, but many lack confidence to discuss newer treatments, according to an exclusive AusDoc survey.
Read more